The role of chemotherapy in patients with small cell lung cancer and poor performance status.
CONCLUSION: Chemotherapy prolongs survival in patients with SCLC and poor PS. Administering an initial attenuated chemotherapy regimen followed by standard full-dose chemotherapy when the PS improves may lower toxicity and improve tolerance.
PMID: 32924733 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Noronha V, Ravind R, Patil VM, Mokal S, Joshi A, Menon N, Kapoor A, Mahajan A, Janu A, Nakti D, Shah L, Shah S, Prabhash K Tags: Acta Oncol Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Men | Small Cell Lung Cancer | Study | Toxicology